The Archives of Cardiovascular Diseases, published by Elsevier Masson, stands as a leading journal in the field of cardiology and cardiovascular medicine, with an impressive impact factor that underscores its relevance and influence. This esteemed journal, recognized in the Q2 category for both cardiology and miscellaneous medicine, aims to disseminate groundbreaking research, innovative methodologies, and clinical advancements that can shape the future of cardiovascular health. With its diverse array of open access options, researchers and students alike have the ability to engage with high-quality content, ensuring that cutting-edge findings are accessible globally. Since its inception in 2008, the journal has actively contributed to the advancement of knowledge in cardiovascular diseases, fostering collaboration among clinicians, researchers, and educators. Headquartered in Paris, France, Archives of Cardiovascular Diseases remains committed to enhancing our understanding of cardiovascular health and improving patient outcomes worldwide.

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, published by SPRINGER, is a renowned journal that has been at the forefront of research in the fields of cardiology and interventional radiology since its inception in 1978. With an ISSN of 0174-1551 and an E-ISSN of 1432-086X, this journal is pivotal for both established researchers and emerging scholars looking to stay updated on advancements in cardiovascular medicine and state-of-the-art imaging techniques. Housed in Germany and respected worldwide, the journal boasts a commendable impact factor and maintains Q2 rankings in both Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine, and Imaging as of 2023, affirming its critical role in shaping future practices and methodologies. As a testament to its quality, it is rated in the 76th and 74th percentiles for its respective Scopus categories. Though not an open-access journal, subscribers gain exclusive access to high-quality, peer-reviewed articles that contribute significantly to the field, cementing its relevance for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular and interventional radiology.

Cardiology Research and Practice is a leading academic journal dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by HINDAWI LTD, this journal has been an inclusive platform for open access research since 2009, facilitating the dissemination of high-quality studies that contribute to the global scientific community. With an impact factor placing it in Q2 of its category in 2023, it underscores its importance in delivering innovative insights and discoveries that shape clinical practices and policies. The journal covers a broad scope of topics including, but not limited to, cardiovascular disease prevention, innovative treatment modalities, and emerging technologies, appealing to researchers, healthcare professionals, and students alike. Located in the United States with its international reach, Cardiology Research and Practice serves as a critical resource for those dedicated to improving patient outcomes and advancing the field of cardiology.

TEXAS HEART INSTITUTE JOURNAL, published by the renowned Texas Heart Institute, stands as a pivotal resource in the field of cardiology and cardiovascular medicine. With a history spanning over four decades since its establishment in 1982, this journal addresses a wide range of topics within its scope, including clinical studies, innovative treatments, and groundbreaking research in heart health. Despite its Q3 ranking in both Cardiology and Cardiovascular Medicine, the journal is committed to fostering advancement in medical knowledge and practice, providing an essential platform for healthcare professionals and researchers alike. While currently lacking open access, the journal is recognized for its contributions to the field, aiming to illuminate critical healthcare discussions and promote the exchange of ideas. For those interested in staying at the forefront of cardiovascular research, TEXAS HEART INSTITUTE JOURNAL offers invaluable insights and the latest developments shaping the future of heart care.

Heart Lung and Circulation, published by Elsevier Science Inc, is a premier peer-reviewed journal that focuses on the dynamic fields of cardiology, cardiovascular medicine, and pulmonary and respiratory medicine. With its ISSN 1443-9506 and E-ISSN 1444-2892, this journal has established itself as a significant contributor to the scientific community since its inception in 2000 and continues to publish cutting-edge research through 2024. Ranked in the Q2 category for both Cardiology and Pulmonary and Respiratory Medicine for 2023, it reflects a strong impact within its discipline. While the journal operates under a subscription model, it offers a comprehensive platform for disseminating significant developments, case studies, and reviews pertinent to practitioners, researchers, and students alike. The journal's focus on bridging the gaps in knowledge surrounding heart and lung physiology underscores its vital role in enhancing patient care and informing clinical practices.

JOURNAL OF INVASIVE CARDIOLOGY, a reputable publication by H M P COMMUNICATIONS, is dedicated to advancing the field of cardiology and cardiovascular medicine through rigorous research and scholarly discussion. With an ISSN of 1042-3931 and an E-ISSN of 1557-2501, this journal serves as a crucial resource for healthcare professionals, researchers, and students who seek to stay informed about the latest findings and innovations in invasive cardiology. Having achieved a 2023 Scopus rank of #185 out of 636 in General Medicine, placing it in the 70th percentile, the journal is recognized for its significant contributions to medical science, evidenced by its Q2 ranking in Radiology, Nuclear Medicine and Imaging, and Q3 status in both Cardiology and Cardiovascular Medicine. The journal has been in circulation since 1990 and continues to foster a platform for critical research in the United States, ensuring accessibility to vital information necessary for enhancing patient care and clinical practices within the domain of invasive procedures.

REVISTA ESPANOLA DE CARDIOLOGIA is a premier journal dedicated to the dynamic field of cardiology, published by EDICIONES DOYMA S A in Barcelona, Spain. With an impressive Q1 status in the Medicine (miscellaneous) category for 2023, this journal is recognized for its significant contributions to cardiovascular research, evidenced by its rank of #61 out of 387 in the Scopus database, placing it within the top 16% of journals in its field. Covering a broad range of topics within cardiology, the journal aims to disseminate high-quality research, clinical studies, and educational content, fostering knowledge sharing among researchers, clinicians, and students alike. While it does not currently offer open access, the journal maintains a commitment to advancing cardiovascular health through rigorous peer-reviewed articles. With a publication history that spans from 2013 to 2024, REVISTA ESPANOLA DE CARDIOLOGIA is an essential resource for those seeking to stay at the forefront of cardiology advancements and practices.

REC-Interventional Cardiology is a prominent open-access journal published by PERMANYER PUBL, focusing on the fields of interventional cardiology and cardiovascular medicine. First launched in 2019, this journal provides a dynamic platform for the dissemination of research findings, review articles, and clinical studies that advance the knowledge and practice in the cardiovascular domain. Based in Barcelona, Spain, REC-Interventional Cardiology aims to bridge the gap between research and clinical implementation, catering to the needs of healthcare professionals, researchers, and students alike. With a current ranking of Q4 in the cardiology category and a position within the 48th percentile on Scopus, the journal is committed to fostering robust academic exchanges and enhancing evidence-based practice. The open-access model facilitates wide dissemination of valuable research, ensuring that critical insights reach a global audience eager to advance in this vital health sector.

JOURNAL OF INTERVENTIONAL CARDIOLOGY, published by Wiley-Hindawi, stands as a pivotal resource in the dynamic fields of Cardiology and Cardiovascular Medicine, as well as Radiology, Nuclear Medicine, and Imaging. With an esteemed Q2 ranking in both categories as of 2023, this journal fosters the dissemination of innovative findings and methodologies in interventional cardiology, bridging the gap between clinical practice and research. Since transitioning to Open Access in 2019, it enhances accessibility and encourages a broader reach for its audience of researchers, professionals, and students. With a wide-ranging scope that extends from its inception in 1988 through to 2024, the journal continually captures significant advancements and trends within the cardiovascular arena, ensuring it remains an essential tool for ongoing education and professional development.

Therapeutic Advances in Cardiovascular Disease, published by SAGE Publications Ltd, is an esteemed open-access journal dedicated to disseminating cutting-edge research in the fields of cardiology and cardiovascular medicine. With an ISSN of 1753-9447 and an E-ISSN of 1753-9455, this journal has positioned itself at the forefront of cardiovascular research since its inception in 2007. The journal has earned a Q2 ranking in both cardiology and pharmacology categories, reflecting its impactful contributions to the science and practice of cardiovascular health. Operating from the United Kingdom, Therapeutic Advances in Cardiovascular Disease provides researchers and practitioners with an accessible platform to share innovative findings and therapeutic strategies, particularly since adopting an open-access model in 2019. By fostering scholarly dialogue and collaboration among professionals, this journal plays a pivotal role in advancing our understanding of cardiovascular diseases and enhancing patient care.